Sir, a couple of questions. Firstly, sir, we've got an approval -- in principle approval for amphetamine product in December across two dosage forms. And you mentioned the market size is $220 million to $230 million per annum, and we are one of the few players to get approval for this. So when can we expect the launch of this product in U.S.? And over a period of time, what kind of market share can we garner?
Okay. And when do we get the final approval, if at all, we get it?